SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VGNX -- Variagenics, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (47)8/11/2001 6:18:46 PM
From: tuck  Read Replies (1) | Respond to of 269
 
Might this be relevant? Registration required, but I reckon most folks here already are registered . . .

>>volume 28 no. 4 pp 361 - 364


Experimentally-derived
haplotypes substantially
increase the efficiency of
linkage disequilibrium
studies

Julie A. Douglas1, 5, Michael Boehnke2, 5,
Elizabeth Gillanders6, Jeffrey M. Trent6 &
Stephen B. Gruber3, 4, 5

nature.com;

Cheers, Tuck